Swedish Orphan Biovitrum Ab (BIOVF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 107,844 | 85,247 | 134,875 | 121,847 | 44,036 |
| Receivables | 529,760 | 544,205 | 575,474 | 441,214 | 460,089 |
| Inventories | 393,441 | 365,318 | 330,201 | 399,238 | 332,777 |
| Other current assets | 94 | 0 | 0 | 0 | 0 |
| TOTAL | $1,245,125 | $1,194,875 | $1,110,911 | $1,023,515 | $890,312 |
| Non-Current Assets | |||||
| PPE Net | 149,846 | 23,669 | 27,153 | 57,484 | 58,206 |
| Investments And Advances | 15,704 | 13,391 | 11,991 | 23,203 | 19,511 |
| Intangibles | 5,578,657 | 5,669,316 | 3,965,288 | 4,480,238 | 4,228,219 |
| Other Non-Current Assets | 147,670 | 79,589 | 86,912 | 89,432 | 66,599 |
| TOTAL | $5,891,877 | $5,785,965 | $4,091,344 | $4,650,357 | $4,372,535 |
| Total Assets | $7,137,002 | $6,980,746 | $5,202,354 | $5,673,873 | $5,262,847 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 371,400 | 831,066 | 574,384 | 206,149 | 437,635 |
| Accounts payable and accrued liabilities | 89,302 | 96,563 | 124,073 | 65,063 | 62,021 |
| Accrued Expenses | 536,760 | 494,886 | 520,572 | 579,152 | 428,152 |
| Other current liabilities | 111,344 | 357,208 | 237,741 | 153,212 | 141,918 |
| TOTAL | $1,191,960 | $1,800,658 | $1,472,329 | $1,021,533 | $1,138,287 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,173,702 | 1,070,871 | 294,426 | 1,023,398 | 1,104,933 |
| Other Non-Current Liabilities | 325,802 | 285,635 | 430,589 | 503,129 | 439,597 |
| TOTAL | $2,132,946 | $1,986,430 | $1,101,298 | $1,946,870 | $1,922,106 |
| Total Liabilities | $3,325,095 | $3,787,088 | $2,573,727 | $2,968,403 | $3,060,393 |
| Shareholders' Equity | |||||
| Common Shares | 18,447 | 18,294 | 16,847 | 19,705 | 18,203 |
| Retained earnings | 2,074,010 | 1,702,587 | 1,565,086 | 1,533,873 | 1,141,993 |
| Other shareholders' equity | 93,654 | -88,077 | 34,784 | -7,695 | -27,686 |
| TOTAL | $3,811,907 | $3,193,658 | $2,628,627 | $2,705,470 | $2,202,454 |
| Total Liabilities And Equity | $7,137,002 | $6,980,746 | $5,202,354 | $5,673,873 | $5,262,847 |